Alyftrek (Tezacaftor, Vanzacaftor and Deutivacaftor)
Tezacaftor, Vanzacaftor and Deutivacaftor comes in 2 pill versions in our database, in 2 strengths, from 1 manufacturer. Check the imprint to tell them apart.
Tezacaftor, Vanzacaftor and Deutivacaftor pill images
20 mg / 4 mg / 50 mg 1 pill
50 mg / 10 mg / 125 mg 1 pill
What is Tezacaftor, Vanzacaftor and Deutivacaftor used for?
Tezacaftor, Vanzacaftor and Deutivacaftor is a cystic fibrosis transmembrane conductance regulator potentiator.
- Medicine type
- Cystic fibrosis transmembrane conductance regulator potentiator
Official uses from the US prescribing label
ALYFTREK is indicated for the treatment of cystic fibrosis (CF) in adult and pediatric patients 6 years of age and older who have a clinical diagnosis of CF and who have at least one variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data (see Table 5) or results in production of CFTR protein.
If the patient's genotype is unknown, an FDA-cleared CF genetic test should be used to confirm the presence of at least one variant in the CFTR gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.